ASHINGTON CENTRAL LIMITED


Directors	Dr A Bell
	CHOPRA, Rakesh
	Dr L Gilfillan
	Mr S Kullar


Company Secretary	GILFILLAN, Lindsay John, Dr


Registered Address	Lintonville Medical Group
	Lintonville Terrace
	Ashington
	NE63 9UT


Registered Number	06430176 (England and Wales)

Notes to the Financial Statements
for the year ended 31 March 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Basis of preparation
	The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

	Functional and presentation currency
	The financial statements are presented in sterling and this is the functional currency of the company.

	Turnover policy
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually at the point of sale and the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and/or the rendering of services.

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually at the point of sale and the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

	Operating leases
	Rentals payable under operating leases are charged to the Income Statement on a straight-line basis over the period of the lease.

	Employee benefits
	Contributions to defined contribution plans are expensed in the period to which they relate. Amounts not paid are shown in accruals in the Statement of Financial Position. The assets of the plan are held separately from the company in independently administered funds.

	Current taxation
	Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

	Deferred tax
	Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

Deferred tax

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. 

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Tangible fixed assets and depreciation
	Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Tangible fixed assets and depreciation

Tangible fixed assets are stated at cost or valuation less depreciation. 

The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement

Depreciation is provided on all tangible fixed assets as follows:


	Reducing balance (%)	Straight line (years)
Plant and machinery	10	-
Fixtures and fittings	15	-
Vehicles	25	-
Office Equipment	-	3

	Investments
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses.

	Finance leases and hire purchase contracts
	Payments made under operating leases are charged to the Income Statement on a straight line basis over the lease term.

	Stocks and work in progress
	Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete). At each date of Statement of Financial Position, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete the sale. The impairment loss is recognised immediately in the Income Statement

	Government grants or assistance
	Grants are accounted under the accruals model as permitted by FRS 102. The deferred element of grants is included in creditors as deferred income. Grants of a revenue nature are recognised in the Income Statement in the same period as the related expenditure.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	16		18

3.	Tangible fixed assets

	Plant & machinery	Vehicles	Fixtures & fittings	Office Equipment	Total
	£	£	£	£	£
Cost or valuation
At 01 April 24	3,592	20,780	21,916	24,437	70,725
Additions	1,800	-	-	9,277	11,077
At 31 March 25	5,392	20,780	21,916	33,714	81,802
Depreciation and impairment
At 01 April 24	3,592	13,151	19,359	24,437	60,539
Charge for year	105	1,907	383	1,400	3,795
At 31 March 25	3,697	15,058	19,742	25,837	64,334
Net book value
At 31 March 25	1,695	5,722	2,174	7,877	17,468
At 31 March 24	-	7,629	2,557	-	10,186

4.	Fixed asset investments
	The Fixed Asset Investment is 100% of the share capital in Ashington Healthcare Limited, a company registered in England and Wales.

	Investments in groups¹	Total
	£	£
Cost or valuation
At 01 April 24	174,019	174,019
At 31 March 25	174,019	174,019
Net book value
At 31 March 25	174,019	174,019
At 31 March 24	174,019	174,019

	Notes
	¹Investments in group undertakings and participating interests

5.	Stocks
	Stocks are estimated at the lower of cost and estimated selling price less estimated costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

	2025	2024
	£	£
Other stocks	57,608	70,710
Total	57,608	70,710

6.	Debtors: amounts due within one year

	2025	2024
	£	£
Trade debtors / trade receivables	302,065	339,014
Other debtors	365,210	319,602
Prepayments and accrued income	4,633	5,327
Total	671,908	663,943


	Other debtors includes an amount of £314,375 (2024 - £279,375) due from the wholly owned subsidiary, Ashington Healthcare Limited.

7.	Creditors: amounts due within one year

	2025	2024
	£	£
Trade creditors / trade payables	171,081	199,734
Taxation and social security	67,952	81,491
Other creditors	428,049	451,378
Accrued liabilities and deferred income	3,599	3,348
Total	670,681	735,951


	Other creditors includes loans totalling £300,000 (2024 - £300,000) due from the company to the directors. These loans are unsecured, interest free and repayable on demand.

8.	Provisions for liabilities

	2025	2024
	£	£
Net deferred tax liability (asset)	4,367	2,547
Total	4,367	2,547

9.	Operating lease commitments
	At 31 March 2025 the company had future minimum lease payments under non-cancellable operating leases of £95,718 (2024 - £128,535).

10.	Parent-subsidiary relationships
	The results of the company's 100% subsidiary Ashington Healthcare Limited are: Income £579,046 (2024 - £181,489); Expenditure £621,231 (2024 - £222,773); Loss £42,185 (2024 - £41,284); Net Assets (£83,364) (2024 - (£41,179).).

	Notes	2025		2024
		£	£	£	£
Fixed assets
Tangible assets	3		17,468		10,186
Investments	4		174,019		174,019
			191,487		184,205
Current assets
Stocks	5	57,608		70,710
Debtors	6	671,908		663,943
Cash at bank and on hand		367,370		240,672
		1,096,886		975,325
Creditors amounts falling due within one year	7	(670,681)		(735,951)
Net current assets (liabilities)			426,205		239,374
Total assets less current liabilities			617,692		423,579
Provisions for liabilities	8		(4,367)		(2,547)
Net assets			613,325		421,032
Capital and reserves
Called up share capital			12		12
Profit and loss account			613,313		421,020
Shareholders' funds			613,325		421,032